Podcasts

The Los Angeles county coroner’s office recently ruled that singer Whitney Houston drowned in her hotel bathtub but that other factors contributed to her demise. Did the 48-year-old have preexisting cardiovascular disease? Did cocaine abuse trigger a deadly cardiac event? Drs Payal Kohli and Christopher Cannon put the autopsy results and the pop star’s final moments in context.

A new study that showed a link between a yearly dental x-ray and meningioma must have sent a shiver down many a spine. Here, oral medicine specialist Dr Jeff Burgess offers guidance about what to think, and how to respond when a concerned patient asks.

With genetic tests rapidly entering medical practice, and some patients even ordering them on their own, the NIH has launched a Genetic Testing Registry to help doctors interpret and follow up on these tests. In this interview, the director of the new Genetic Testing Registry tells why you need it, and what's there for your reference.

A consortium called CPIC has issued a new guideline on genetic tests that can mean the difference between toxic reactions or unrelieved pain for some patients on codeine. Dr. Mary Relling tells why primary care doctors need good information right now about the links between genes and drug response, and where you can find it.

The FDA will launch an intensive review of data on the safety of metal-on-metal hip implants in June, responding to yet more evidence that they present a high risk of failure and revision surgery. Listen as orthopedic surgeon William Maloney of Stanford University School of Medicine discusses the risks and the realities of hip replacement today.

Statins have been shown to significantly reduce the risk of heart attacks, heart disease and death. But this week, the FDA decided that the package inserts of the various statins must now include a warning that these agents may raise blood glucose levels and that they can cause memory loss. Here to put this issue into perspective are Drs Christopher Cannon and Payal Kohli.

Data from a long-term prospective study reveal that for many older women, the pace of bone mass deterioration takes place on the scale of decades, not single years. Here, the lead author of the study describes how to interpret the results to choose the date for your own patient's next bone density test.

In the next few minutes, nationally recognized expert, Dr Robert Schoen, will discuss the latest findings on Lyme disease.